Cargando…

Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes

Primary small cell carcinoma of the esophagus (PSCCE) is a lethal neuroendocrine carcinoma. Previous studies proposed a genetic similarity between PSCCE and esophageal squamous cell carcinoma (ESCC) but provided little evidence for differences in clinical course and neuroendocrine differentiation. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Renda, Yang, Zhenlin, Shao, Fei, Cheng, Hong, Wen, Yaru, Sun, Sijin, Guo, Wei, Li, Zitong, Zhang, Fan, Xue, Liyan, Bi, Nan, Wang, Jie, Sun, Yingli, Li, Yin, Tan, Fengwei, Xue, Qi, Gao, Shugeng, Shi, Susheng, Gao, Yibo, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213753/ https://www.ncbi.nlm.nih.gov/pubmed/34145257 http://dx.doi.org/10.1038/s41467-021-24043-6

Ejemplares similares

Characteristics and Surgical Outcomes for Primary Malignant Melanoma of the Esophagus
por: Gao, Shugeng, et al.
Publicado: (2016)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Tiejun, et al.
Publicado: (2022)

Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Specific organ metastases and prognosis in lung adenocarcinoma
por: Zhao, Ziran, et al.
Publicado: (2023)

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer
por: Zhao, Ziran, et al.
Publicado: (2023)

Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma
por: Yang, Zhenlin, et al.
Publicado: (2020)

Sintilimab for the treatment of non-small cell lung cancer
por: Zhang, Lin, et al.
Publicado: (2022)

Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2020)

The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer
por: Wang, Juhong, et al.
Publicado: (2022)

PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer
por: Yang, Zhenlin, et al.
Publicado: (2021)

Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2020)

High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation
por: Wang, Chunni, et al.
Publicado: (2017)

Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma
por: Gao, Shugeng, et al.
Publicado: (2021)

Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma
por: Guo, Wei, et al.
Publicado: (2022)

Multimodality Treatment of Pulmonary Sarcomatoid Carcinoma: A Review of Current State of Art
por: Zhang, Lin, et al.
Publicado: (2022)

Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
por: Sun, Sijin, et al.
Publicado: (2021)

Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis
por: Shao, Fei, et al.
Publicado: (2019)

Prognostic value of tumor-infiltrating lymphocytes in esophageal cancer: an updated meta-analysis of 30 studies with 5,122 patients
por: Gao, Yibo, et al.
Publicado: (2020)

Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer
por: Guo, Wei, et al.
Publicado: (2022)

Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma
por: Gao, Yibo, et al.
Publicado: (2019)

Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients
por: Zeng, Qingpeng, et al.
Publicado: (2021)

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis
por: Fan, Tao, et al.
Publicado: (2021)

Submucosal gland neoplasms of the esophagus: an update and review
por: Nie, Ling, et al.
Publicado: (2020)

Collision tumor of the esophagus: a report of five cases
por: Zhang, Guo-Chao, et al.
Publicado: (2020)

Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2022)

METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N(6)-methyladenosine-dependent YTHDF binding
por: Wang, Wei, et al.
Publicado: (2021)

Author Correction: METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N(6)-methyladenosine-dependent YTHDF binding
por: Wang, Wei, et al.
Publicado: (2021)

Prognostic value of PD-L1 in esophageal squamous cell carcinoma: a meta-analysis
por: Guo, Wei, et al.
Publicado: (2017)

Exosomes: New players in cancer
por: Guo, Wei, et al.
Publicado: (2017)

Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer
por: Liu, Zixu, et al.
Publicado: (2023)

Comprehensive analyses of N (6)‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer
por: Luo, Yuejun, et al.
Publicado: (2022)

Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?
por: Yuan, Zuyang, et al.
Publicado: (2020)

Prognostic Impact of Metabolism Reprogramming Markers Acetyl-CoA Synthetase 2 Phosphorylation and Ketohexokinase-A Expression in Non-Small-Cell Lung Carcinoma
por: Yang, Xueying, et al.
Publicado: (2019)

m(6)A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability
por: Wang, Juhong, et al.
Publicado: (2022)

AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression
por: Shi, Xuejiao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jj5g0ok8vv2799bf47qgdjs4pu